5442932026-04-012026-06-305442932026-04-012026-06-30in-capmkt:OtherExpenses1Member5442932026-04-012026-06-30in-capmkt:OtherExpenses2Member5442932026-04-012026-06-30in-capmkt:OtherExpenses3Member5442932026-04-012026-06-30in-capmkt:OtherExpenses4Member5442932026-04-012026-06-30in-capmkt:OtherExpenses5Member5442932026-04-012026-06-30in-capmkt:OtherExpenses6Member5442932026-04-012026-06-30in-capmkt:OtherExpenses7Member5442932026-04-012026-06-30in-capmkt:OtherExpenses8Member5442932026-04-012026-06-30in-capmkt:OtherExpenses9Member5442932026-04-012026-06-30in-capmkt:OtherExpenses10Member5442932026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15442932026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25442932026-04-012026-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544293SURAKSHANOTLISTEDINE877V01027SURAKSHA DIAGNOSTIC LIMITEDMain BoardEquity2026-04-012027-03-312026-08-122026-08-04INRLakhsQuarterlyFirst quarterSingle segmentDIAGNOSTIC2026-08-1215:00:002026-08-1216:30:00Declaration of unmodified opinion2026-04-012026-06-30UnauditedConsolidated87645400010877000887331000999500000014411800037221000112822000327962000722073000165258000016525800042431000-562700036804000012845400000001284540001424000129878000130080000-1626000131504000-162600010416200022.52.5002.52.50001. The unaudited consolidated financial results for the quarter ended 30 June 2026 (“the financial results”) of Suraksha Diagnostic Limited (“the Holding Company”) and its subsidiary (Holding company and subsidiaries together referred to as ‘the group’) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard (Ind AS) notified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and other accounting principles generally accepted in India and in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the regulations”). <br /> These unaudited consolidated financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on 12 August 2026. The statutory auditor have carried out limited review on these financial results and have issued an unmodified conclusion. <br /> 2. The figures of the quarters ended 31 March 2026 is balancing figures between the audited figures in respect of the full financial year and the published figures of nine months ended 31 December 2025, which were subjected to limited review by the statutory auditors. <br /> 3. The Group is primarily engaged in the business of diagnostic centres for carrying out various pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 – ‘Operating Segments’. <br /> 4. These unaudited consolidated financial results are also available on the Holding Company's website (www.surakshanet.com) and on the stock exchange websites (www.bseindia.com and www.nseinda.com). <br /> 5. Previous period's/year's figures have been regrouped/reclassified wherever necessary to conform to current period’s/ year's classification. <br /> Impairment Loss-520000Advertisement8142000Rent Expenses13765000Power and fuel25241000Professional fees paid151489000Repairs and maintenance17513000Information technology expenses15008000Security and housekeeping charges24583000Commission to collection centre17401000Other Expenses55340000Remeasurement gain/(loss) of net defined benefit plan1902000Income tax effect on above-4780001424000001424000UnauditedtrueMSKA & Associatestrue2027-07-31